BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:11 PM
Sep 21, 2009
 |  BC Extra  |  Clinical News

NIAID reports pediatric H1N1 vaccine data

NIH's National Institute of Allergy and Infectious Diseases reported preliminary data from a Phase II trial evaluating a swine influenza A (H1N1) vaccine from sanofi-aventis Group (Euronext:SAN; NYSE:SNY). At 8-10 days post-vaccination, a single 15 ug intramuscular dose of...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >